The Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH) in the province of Holguín, the only one of its kind in Cuba, prioritizes the follow-up programs for its patients, amid the epidemiological contingency generated by COVID -19, widespread on the Caribbean island.
Cubans who received Nasalferon drug in February (99.4 percent of 100,000) have shown optimal results to fight Covid-19.
This city in eastern Cuba is preparing today for the third phase of clinical trials of the Abdala Covid-19 vaccine candidate, which it will share with Guantanamo, after conducting two previous ones with good results.
During the meeting of the Temporary Working Group for the prevention and control of the COVID epidemic, headed by the Cuban President Miguel Díaz-Canel Bermúdez, the Second Secretary of the Communist Party of Cuba José Ramón Machado Ventura and Prime Minister Manuel Marrero Cruz, the Cuban deputy prime minister stressed that last week Cuba, recorded the third 7-day period of dismal results regarding positive COVID-19 cases, since the pandemic was declared nearly one year ago.